Testing effectiveness (Phase 2)Study completedNCT00992771
What this trial is testing
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Who this might be right for
Spinocerebellar Ataxia Type 3
University of South Florida 20